Lord Abbett Health Care Fund Class F (LHCFX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
18.02
+0.07 (0.39%)
May 30, 2025, 4:00 PM EDT
-5.56% (1Y)
Fund Assets | 3.27M |
Expense Ratio | 0.78% |
Min. Investment | $0.00 |
Turnover | n/a |
Dividend (ttm) | 0.09 |
Dividend Yield | 0.49% |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | Nov 26, 2024 |
Previous Close | 17.95 |
YTD Return | -7.11% |
1-Year Return | -5.15% |
5-Year Return | 26.23% |
52-Week Low | 16.76 |
52-Week High | 21.11 |
Beta (5Y) | n/a |
Holdings | 66 |
Inception Date | Jul 31, 2019 |
About LHCFX
The Fund's investment strategy focuses on Health/Biotech with 0.78% total expense ratio. Lord Abbett Securities Trust: Lord Abbett Health Care Fund; Class F Shares seeks long-term capital appreciation. Under normal market conditions, LHCFX will invest at least 80% of its assets in equity and equity-related securities of health care-related companies. LHCFX may invest in the securities of issuers of different countries throughout the world, including the United States.
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol LHCFX
Share Class Class F
Index MSCI ACWI/Health Care NR Index
Performance
LHCFX had a total return of -5.15% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.76%.
Top 10 Holdings
40.46% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 8.74% |
Boston Scientific Corporation | BSX | 4.92% |
Intuitive Surgical, Inc. | ISRG | 4.78% |
Gilead Sciences, Inc. | GILD | 3.94% |
Stryker Corporation | SYK | 3.74% |
argenx SE | ARGX | 3.56% |
Natera, Inc. | NTRA | 3.06% |
Tarsus Pharmaceuticals, Inc. | TARS | 2.94% |
Cencora, Inc. | COR | 2.61% |
UCB SA | UCB | 2.14% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Nov 26, 2024 | $0.0882 | Nov 26, 2024 |
Nov 23, 2021 | $1.4724 | Nov 23, 2021 |
Nov 24, 2020 | $2.3119 | Nov 24, 2020 |
Nov 21, 2019 | $0.0011 | Nov 21, 2019 |